JCB in the News

Feb. 16, 2012 Pharmaceuticals lab thrives in Wichita - The Wichita Eagle

Nov. 11, 2011 Bioscience authority provides $225K grant for JCB Labs expansion - The Wichita Eagle

 Sep. 7, 2011 Busy JCB Labs renovating new location for expansion - The Wichita Eagle

 

Drug Shortages Update

NEWS

Current Articles | RSS Feed RSS Feed

6 Things to Know About Pharmaceuticals and Outsourcing Pharmaceutical Solutions

Brian Williamson, PharmD, president & CEO of JCB Laboratories, a compounding pharmacy that serves ambulatory surgery centers, hospitals and clinics, discusses six things ASC should know about pharmaceuticals and outsourcing pharmaceutical solutions.

Read more >>

Rockers to head JCB's research efforts

JCB Laboratories announced that Greg Rockers, R.Ph. has joined JCB Laboratories as Vice President of the newly formed Pharmaceutical Research and Clinical Trial division.

Greg brings to JCB Labs broad experience from within the healthcare industry. Most recently, he was the Director of Pharmacy at The Wichita Clinic. In that role, Greg was also in charge of the clinical research department. Prior to that, Greg held several positions at home infusion companies. He obtained his pharmacy degree at The University of Kansas School of Pharmacy.

“Our organization has been built with people who display commitment and passion for the sterile products industry. Greg’s demonstrable leadership and laser focus on detail is a valuable addition to the JCB Laboratories executive team. We look forward to Greg’s innovative thinking while helping JCB grow an agile, responsive, and service oriented company,” Williamson stated.

JCB signs Agreement with MedAssets

JCB Laboratories has signed an agreement with MedAssets to provide compounded sterile products to their ASC clients. This agreement was born from the requests of the ASCs to find a competent and competitively priced sterile products compounding pharmacy. The need for quality, unadulterated sterile products is in high demand. JCB is looking forward to being the premiere sterile products compounding pharmacy in the country. The executive team at JCB Labs believes this agreement with MedAssets is a significant endorsement of their quality and attention to the specifics that keep patients safe and facilities out of court.

3 Options to Meet USP 797 Requirements for Combination Ophthalmic Dilating Drops

Dilating patients' eyes before ophthalmic procedures is quite possibly the most time-consuming part of the eye exam/surgery. Many facilities choose to combine various medications to ensure a more efficient pre-operative process.
Read more >>

JCB announces contract with INN

JCB Laboratories has announced a new contract with INN to provide compounded sterile products to their renal dialysis clinics. JCB is looking forward to being the premier sterile products compounding pharmacy for INN surgery centers.

JCB enters agreement with Renal Purchasing Group

JCB Laboratories has announced a new contract with RPG to provide compounded sterile products to their renal dialysis clinics. JCB is looking forward to being the premier sterile products compounding pharmacy for RPG dialysis centers.

USP 797 and Its Effect on ASCs

By now, you have probably heard about USP 797 or simply 797. If you are at all involved in anesthesia, you are also probably generally aware of what 797 is all about. But it’s a big issue with many facets, so regardless, you may be wondering when, what, who, where and how this will affect your ASC.
Read more >>

All Posts
Follow JCB